- IBDEI2HK ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,39697,2)
- ;;=^5002392
- ;;^UTILITY(U,$J,358.3,39698,0)
- ;;=D47.Z9^^152^2000^178
- ;;^UTILITY(U,$J,358.3,39698,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39698,1,3,0)
- ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
- ;;^UTILITY(U,$J,358.3,39698,1,4,0)
- ;;=4^D47.Z9
- ;;^UTILITY(U,$J,358.3,39698,2)
- ;;=^5002262
- ;;^UTILITY(U,$J,358.3,39699,0)
- ;;=D05.82^^152^2000^35
- ;;^UTILITY(U,$J,358.3,39699,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39699,1,3,0)
- ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
- ;;^UTILITY(U,$J,358.3,39699,1,4,0)
- ;;=4^D05.82
- ;;^UTILITY(U,$J,358.3,39699,2)
- ;;=^5001934
- ;;^UTILITY(U,$J,358.3,39700,0)
- ;;=D05.81^^152^2000^37
- ;;^UTILITY(U,$J,358.3,39700,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39700,1,3,0)
- ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
- ;;^UTILITY(U,$J,358.3,39700,1,4,0)
- ;;=4^D05.81
- ;;^UTILITY(U,$J,358.3,39700,2)
- ;;=^5001933
- ;;^UTILITY(U,$J,358.3,39701,0)
- ;;=D05.80^^152^2000^39
- ;;^UTILITY(U,$J,358.3,39701,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39701,1,3,0)
- ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
- ;;^UTILITY(U,$J,358.3,39701,1,4,0)
- ;;=4^D05.80
- ;;^UTILITY(U,$J,358.3,39701,2)
- ;;=^5001932
- ;;^UTILITY(U,$J,358.3,39702,0)
- ;;=D56.8^^152^2000^191
- ;;^UTILITY(U,$J,358.3,39702,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39702,1,3,0)
- ;;=3^Thalassemias,Other
- ;;^UTILITY(U,$J,358.3,39702,1,4,0)
- ;;=4^D56.8
- ;;^UTILITY(U,$J,358.3,39702,2)
- ;;=^5002305
- ;;^UTILITY(U,$J,358.3,39703,0)
- ;;=C82.89^^152^2000^77
- ;;^UTILITY(U,$J,358.3,39703,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39703,1,3,0)
- ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
- ;;^UTILITY(U,$J,358.3,39703,1,4,0)
- ;;=4^C82.89
- ;;^UTILITY(U,$J,358.3,39703,2)
- ;;=^5001540
- ;;^UTILITY(U,$J,358.3,39704,0)
- ;;=D51.8^^152^2000^198
- ;;^UTILITY(U,$J,358.3,39704,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39704,1,3,0)
- ;;=3^Vitamin B12 Deficiency Anemias,Other
- ;;^UTILITY(U,$J,358.3,39704,1,4,0)
- ;;=4^D51.8
- ;;^UTILITY(U,$J,358.3,39704,2)
- ;;=^5002288
- ;;^UTILITY(U,$J,358.3,39705,0)
- ;;=I80.9^^152^2000^183
- ;;^UTILITY(U,$J,358.3,39705,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39705,1,3,0)
- ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
- ;;^UTILITY(U,$J,358.3,39705,1,4,0)
- ;;=4^I80.9
- ;;^UTILITY(U,$J,358.3,39705,2)
- ;;=^93357
- ;;^UTILITY(U,$J,358.3,39706,0)
- ;;=D45.^^152^2000^184
- ;;^UTILITY(U,$J,358.3,39706,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39706,1,3,0)
- ;;=3^Polycythemia Vera
- ;;^UTILITY(U,$J,358.3,39706,1,4,0)
- ;;=4^D45.
- ;;^UTILITY(U,$J,358.3,39706,2)
- ;;=^96105
- ;;^UTILITY(U,$J,358.3,39707,0)
- ;;=C77.3^^152^2000^113
- ;;^UTILITY(U,$J,358.3,39707,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39707,1,3,0)
- ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
- ;;^UTILITY(U,$J,358.3,39707,1,4,0)
- ;;=4^C77.3
- ;;^UTILITY(U,$J,358.3,39707,2)
- ;;=^5001330
- ;;^UTILITY(U,$J,358.3,39708,0)
- ;;=C77.2^^152^2000^129
- ;;^UTILITY(U,$J,358.3,39708,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39708,1,3,0)
- ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
- ;;^UTILITY(U,$J,358.3,39708,1,4,0)
- ;;=4^C77.2
- ;;^UTILITY(U,$J,358.3,39708,2)
- ;;=^267316
- ;;^UTILITY(U,$J,358.3,39709,0)
- ;;=C77.1^^152^2000^130
- ;;^UTILITY(U,$J,358.3,39709,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39709,1,3,0)
- ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2HK 3784 printed Mar 13, 2025@21:33:42 Page 2
- IBDEI2HK ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,39697,2)
- +2 ;;=^5002392
- +3 ;;^UTILITY(U,$J,358.3,39698,0)
- +4 ;;=D47.Z9^^152^2000^178
- +5 ;;^UTILITY(U,$J,358.3,39698,1,0)
- +6 ;;=^358.31IA^4^2
- +7 ;;^UTILITY(U,$J,358.3,39698,1,3,0)
- +8 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
- +9 ;;^UTILITY(U,$J,358.3,39698,1,4,0)
- +10 ;;=4^D47.Z9
- +11 ;;^UTILITY(U,$J,358.3,39698,2)
- +12 ;;=^5002262
- +13 ;;^UTILITY(U,$J,358.3,39699,0)
- +14 ;;=D05.82^^152^2000^35
- +15 ;;^UTILITY(U,$J,358.3,39699,1,0)
- +16 ;;=^358.31IA^4^2
- +17 ;;^UTILITY(U,$J,358.3,39699,1,3,0)
- +18 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
- +19 ;;^UTILITY(U,$J,358.3,39699,1,4,0)
- +20 ;;=4^D05.82
- +21 ;;^UTILITY(U,$J,358.3,39699,2)
- +22 ;;=^5001934
- +23 ;;^UTILITY(U,$J,358.3,39700,0)
- +24 ;;=D05.81^^152^2000^37
- +25 ;;^UTILITY(U,$J,358.3,39700,1,0)
- +26 ;;=^358.31IA^4^2
- +27 ;;^UTILITY(U,$J,358.3,39700,1,3,0)
- +28 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
- +29 ;;^UTILITY(U,$J,358.3,39700,1,4,0)
- +30 ;;=4^D05.81
- +31 ;;^UTILITY(U,$J,358.3,39700,2)
- +32 ;;=^5001933
- +33 ;;^UTILITY(U,$J,358.3,39701,0)
- +34 ;;=D05.80^^152^2000^39
- +35 ;;^UTILITY(U,$J,358.3,39701,1,0)
- +36 ;;=^358.31IA^4^2
- +37 ;;^UTILITY(U,$J,358.3,39701,1,3,0)
- +38 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
- +39 ;;^UTILITY(U,$J,358.3,39701,1,4,0)
- +40 ;;=4^D05.80
- +41 ;;^UTILITY(U,$J,358.3,39701,2)
- +42 ;;=^5001932
- +43 ;;^UTILITY(U,$J,358.3,39702,0)
- +44 ;;=D56.8^^152^2000^191
- +45 ;;^UTILITY(U,$J,358.3,39702,1,0)
- +46 ;;=^358.31IA^4^2
- +47 ;;^UTILITY(U,$J,358.3,39702,1,3,0)
- +48 ;;=3^Thalassemias,Other
- +49 ;;^UTILITY(U,$J,358.3,39702,1,4,0)
- +50 ;;=4^D56.8
- +51 ;;^UTILITY(U,$J,358.3,39702,2)
- +52 ;;=^5002305
- +53 ;;^UTILITY(U,$J,358.3,39703,0)
- +54 ;;=C82.89^^152^2000^77
- +55 ;;^UTILITY(U,$J,358.3,39703,1,0)
- +56 ;;=^358.31IA^4^2
- +57 ;;^UTILITY(U,$J,358.3,39703,1,3,0)
- +58 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
- +59 ;;^UTILITY(U,$J,358.3,39703,1,4,0)
- +60 ;;=4^C82.89
- +61 ;;^UTILITY(U,$J,358.3,39703,2)
- +62 ;;=^5001540
- +63 ;;^UTILITY(U,$J,358.3,39704,0)
- +64 ;;=D51.8^^152^2000^198
- +65 ;;^UTILITY(U,$J,358.3,39704,1,0)
- +66 ;;=^358.31IA^4^2
- +67 ;;^UTILITY(U,$J,358.3,39704,1,3,0)
- +68 ;;=3^Vitamin B12 Deficiency Anemias,Other
- +69 ;;^UTILITY(U,$J,358.3,39704,1,4,0)
- +70 ;;=4^D51.8
- +71 ;;^UTILITY(U,$J,358.3,39704,2)
- +72 ;;=^5002288
- +73 ;;^UTILITY(U,$J,358.3,39705,0)
- +74 ;;=I80.9^^152^2000^183
- +75 ;;^UTILITY(U,$J,358.3,39705,1,0)
- +76 ;;=^358.31IA^4^2
- +77 ;;^UTILITY(U,$J,358.3,39705,1,3,0)
- +78 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
- +79 ;;^UTILITY(U,$J,358.3,39705,1,4,0)
- +80 ;;=4^I80.9
- +81 ;;^UTILITY(U,$J,358.3,39705,2)
- +82 ;;=^93357
- +83 ;;^UTILITY(U,$J,358.3,39706,0)
- +84 ;;=D45.^^152^2000^184
- +85 ;;^UTILITY(U,$J,358.3,39706,1,0)
- +86 ;;=^358.31IA^4^2
- +87 ;;^UTILITY(U,$J,358.3,39706,1,3,0)
- +88 ;;=3^Polycythemia Vera
- +89 ;;^UTILITY(U,$J,358.3,39706,1,4,0)
- +90 ;;=4^D45.
- +91 ;;^UTILITY(U,$J,358.3,39706,2)
- +92 ;;=^96105
- +93 ;;^UTILITY(U,$J,358.3,39707,0)
- +94 ;;=C77.3^^152^2000^113
- +95 ;;^UTILITY(U,$J,358.3,39707,1,0)
- +96 ;;=^358.31IA^4^2
- +97 ;;^UTILITY(U,$J,358.3,39707,1,3,0)
- +98 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
- +99 ;;^UTILITY(U,$J,358.3,39707,1,4,0)
- +100 ;;=4^C77.3
- +101 ;;^UTILITY(U,$J,358.3,39707,2)
- +102 ;;=^5001330
- +103 ;;^UTILITY(U,$J,358.3,39708,0)
- +104 ;;=C77.2^^152^2000^129
- +105 ;;^UTILITY(U,$J,358.3,39708,1,0)
- +106 ;;=^358.31IA^4^2
- +107 ;;^UTILITY(U,$J,358.3,39708,1,3,0)
- +108 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
- +109 ;;^UTILITY(U,$J,358.3,39708,1,4,0)
- +110 ;;=4^C77.2
- +111 ;;^UTILITY(U,$J,358.3,39708,2)
- +112 ;;=^267316
- +113 ;;^UTILITY(U,$J,358.3,39709,0)
- +114 ;;=C77.1^^152^2000^130
- +115 ;;^UTILITY(U,$J,358.3,39709,1,0)
- +116 ;;=^358.31IA^4^2
- +117 ;;^UTILITY(U,$J,358.3,39709,1,3,0)
- +118 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
